PubRank

M A Bonilla

Author PubWeight™ 28.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000 3.45
2 Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 1996 2.59
3 A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993 2.29
4 Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1987 2.17
5 Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 1998 1.56
6 Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000 1.54
7 Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 1988 1.30
8 Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 1994 1.26
9 Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 1996 1.18
10 Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med 1989 1.12
11 Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997 1.10
12 Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988 1.07
13 Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer Res 1994 1.05
14 Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 1994 1.00
15 Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 1995 0.95
16 Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. J Parasitol 1998 0.85
17 International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. J Clin Oncol 1996 0.84
18 Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates. Transplant Proc 1987 0.82
19 Entomofauna resource distribution associated with pig cadavers in Bogotá DC. Med Vet Entomol 2010 0.79
20 Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow. Blood 1987 0.79
21 Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. Eur J Cancer 1997 0.79
22 Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. J Clin Invest 1990 0.76
23 Correction of neutropenia with rHuG-CSF after loss of response to rHuGM-CSF following autologous bone marrow transplant. Bone Marrow Transplant 1994 0.75
24 Effects of in vivo administration of human recombinant IL-2 to cynomolgus monkeys after autologous bone marrow transplantation. Transplant Proc 1987 0.75
25 Recombinant human granulocyte-colony stimulating factor: in vivo effects on myelopoiesis in primates. Behring Inst Mitt 1988 0.75
26 [1st case of human hepatic hydatidosis in Costa Rica]. Rev Cubana Med Trop 1978 0.75
27 Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis. Blood Cells 1987 0.75